TOP TIERMARKET NEWSWIRE
News & sentiment

IMMUNIC INC (IMUX) — News & AI sentiment

IMMUNIC INC (IMUX) news roundup. 1 story in the last 24 hours, 2 in the past week, 11 over 30 days. Average 24-hour sentiment is 52/100 — neutral (50 is neutral). No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
1
avg sentiment 52/100
7d stories
2
avg sentiment 57.5/100
30d stories
11
avg sentiment 56.1/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

IMUX news in the last 24 hours, 7 days, 30 days and 90 days

How much IMUX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowIMUX storiesAvg AI sentimentRead
Last 24 hours152/100IMUX headlines →
Last 7 days257.5/100IMUX headlines →
Last 30 days1156.1/100IMUX headlines →
Last 90 days3755.6/100IMUX headlines →

Latest stories on IMUX

15h ago
5d ago
Oct 21
Oct 21
Oct 20
Oct 19
Oct 19
Oct 13
Oct 7
Oct 7
Sep 29
IMMUNIC, INC. (IMUX) files 8-K
SEC 8-K50 · neutralgeneral
Sep 11
Sep 11
Sep 10
Stifel reiterates Immunic stock rating on MS drug potential
Investing.com Analyst Ratings56 · neutralanalyst
Sep 10
H.C. Wainwright reiterates Immunic stock rating on MS drug progress
Investing.com Analyst Ratings56 · neutralanalyst
Sep 10
Sep 9
Sep 9
IMMUNIC, INC. (IMUX) files 8-K
SEC 8-K50 · neutralgeneral
Sep 9
Sep 2
Sep 1
Sep 1
Sep 1
Sep 1
Aug 25
Open IMUX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →